Fed Circuit dismisses Momenta appeal in BMS suit

08-02-2019

Fed Circuit dismisses Momenta appeal in BMS suit

GoldenBrown / Shutterstock.com

The US Court of Appeals for the Federal Circuit yesterday dismissed an appeal by Massachusetts-based biotech Momenta Pharmaceuticals in a case involving a rheumatoid arthritis drug.


Momenta Pharmaceuticals, BMS, patent, patent infringement, biosimilar, PTAB, US Court of Appeals for the Federal Circuit, Orencia, arthritis, standing

LSIPR